Skip to main content

Vote today for RTP’s UVision360 Hysteroscopy Systems

RTP's UVision 360 has been chosen by Medical Device and Diagnostic Industry (MD+DI), a print and online magazine, to participate in its annual Medtech Startup Showdown. North Carolina's life science and technology community can ensure one of our own makes it to Round 2 by voting now.

Humacyte Vessel Gets Special FDA Review Designation

Humacyte, a Research Triangle Park-based biotechnology company focused on regenerative medicine, has won one of the first Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration

TransEnterix Robotic System Proving Value in Hernia Repair

TransEnterix, a Morrisville medical device company that uses robotics to improve minimally invasive surgery, has expanded the clinical adoption of its Senhance Robotic Surgical System to include a full range of hernia repairs.

Positive Early Phase 2 Lung Cancer Data Buoy Heat Bio

Heat Biologics (Nasdaq:HTBX) has reported early positive results in a Phase 2 trial of its immunotherapy lung cancer treatment.

Durham's Qualyst Launches New Test for Avoiding Liver Toxicity

Durham-based Qualyst Transporter Systems (QTS) has launched a new test that can steer drug developers away from compounds that could cause liver damage.

Bioventus Commissions New Clinical Tests of Ultrasound Bone Healing System

Bioventus, a Durham-based orthobiologics company, says it will commission a series of clinical studies to further validate the ability of its EXOGEN Ultrasound Bone Healing System to lessen the risk of a fracture not healing properly in the presence of known risk factors.

Heat Biologics Gets Good News from Early Cancer Trial

Heat Biologics, a Durham company developing immunotherapies to fight cancer, has reported positive results from a Phase 1b trial of its combination treatment for non-small cell lung cancer.

Panaceutics Scaling up for Customized Production in Personalized Medicine, Nutrition

The Research Triangle Park-based personalized medicine and clinical nutrition company formerly known as Panacea BioMatx is quickly transforming itself in 2017.

'Synergy' Behind Heat Biologics/Pelican deal is Key to Immunology

When Heat Biologics licensed the immune system stimulating technology behind its ImPACT and ComPACT platforms from the University of Miami, it also licensed the tech behind Pelican Therapeutics Inc.

Heat Biologics Acquires Synergistic Austin-based Immune Therapy Firm

Durham-based Heat Biologics Inc. (Nasdaq:HTBX), has inked a deal to acquire an 80 percent controlling interest in Pelican Therapeutics Inc., an immune oncology company based in Austin, Texas.


Subscribe to RSS - Triangle